Peptide record

TPDB20117

Antibacterial Toxicity standard
21 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB20117
Antibacterial Toxicity
Anti-infective peptides Toxicity and safety peptides
Peptipedia
standard
No
A 21-aa standard natural multi-activity (Antibacterial and Toxicity) peptide sequence curated from Peptipedia, with an available 3D structural model.
Sequence
GILSGLLGAGKKLACGLIGLC
Physicochemical Analysis
C87H157N23O23S2
RNDEQHMFPTWYV
GL
1957.46
9.11
2
0
10
+2
-2.63
1.400
158.10
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
125
6.39
3
Residue Composition
number
2
A
0
R
0
N
0
D
2
C
0
E
0
Q
6
G
0
H
2
I
6
L
2
K
0
M
0
F
0
P
1
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 2 R: 0 N: 0 D: 0 C: 2 E: 0 Q: 0 G: 6 H: 0 I: 2 L: 6 K: 2 M: 0 F: 0 P: 0 S: 1 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
21
C87H157N23O23S2
1957.46
9.11
+2
-2.63
1.400
Evidence Records 4 records
Evidence 1 Activity

Activity

MIC
Antibacterial
8 µg/mL

Target

Escherichia coli ATCC 25922

Source & Reference

NA

Other

Active against E. coli ATCC 25922 (MIC 8 ug/ml), S. enteritidis (MIC 32-64 ug/ml), and S. aureus ATCC 29213 (MIC 8-16 ug/ml).
Evidence 2 Activity

Activity

MIC
Antibacterial
32-64 µg/mL

Target

S. enteritidis

Source & Reference

NA

Other

Active against E. coli ATCC 25922 (MIC 8 ug/ml), S. enteritidis (MIC 32-64 ug/ml), and S. aureus ATCC 29213 (MIC 8-16 ug/ml).
Evidence 3 Activity

Activity

MIC
Antibacterial
8-16 µg/mL

Target

Staphylococcus aureus ATCC 29213

Source & Reference

NA

Other

Active against E. coli ATCC 25922 (MIC 8 ug/ml), S. enteritidis (MIC 32-64 ug/ml), and S. aureus ATCC 29213 (MIC 8-16 ug/ml).
Evidence 4 Activity

Activity

50% Hemolysis
Toxicity
>128 µg/mL
Hemolytic Cytotoxic
50% Hemolysis | >128 | µg/mL | target cell: Pig erythrocytes

Target

Pig erythrocytes

Source & Reference

NA
DBAASP
Associating Biological Activity and Predicted Structure of Antimicrobial Peptides from Amphibians and Insects | Antibiotics (Basel) | 2022